NICE OKs £20m budget impact limit for new drugs

Pharma Times ------- The pharma industry and patient groups are warning of significant delays in accessing innovative medicines on the NHS after a new budget impact threshold was waved through by health officials. The National Institute for Health and Care Excellence (NICE) has now confirmed that, from next month, any new medicines found to be cost effective but likely to overshoot the budget impact limit of £20 million during the first three years will be subject to a second process for price negotiation before they can be made available on the NHS. To get more in depth information click on the picture below to read the article.